Document:

Form of Stock Purchase Warrant

 Exhibit 10.28 
  
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS, AND MAY BE OFFERED
AND SOLD ONLY IF SO REGISTERED OR IF AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE. 
  
 STOCK PURCHASE WARRANT 
  

			
	 Date of Issuance: June     , 2004
	  	Certificate No. W04-            

  
 For value received,
HEALTHESSENTIALS SOLUTIONS, INC., a Delaware corporation (the “Company”), hereby grants
to                                       
 , or its permitted transferees and assigns, the right to purchase from the Company that number of Warrant Shares (as defined herein) calculated as set forth on Schedule I attached hereto at a price per share of $0.00001 (the
“Initial Exercise Price”). The exercise price and number of Warrant Shares (and the amount and kind of other securities) for which this Warrant is exercisable shall be subject to adjustment as provided herein. Certain capitalized
terms used herein are defined in Section 4 hereof. 
  
 This
Warrant is subject to the following provisions: 
  
 Section 1.
Exercise of Warrant. 
  
 1.1. Exercise
Period. In the event that all outstanding amounts under the Notes (as defined in the Warrant Agreement) are not paid in full by December 31, 2004, the purchase rights represented by this Warrant may be exercised, in whole or in part, at any time
and from time to time after January 1, 2005 to and including 5:00 p.m., New York time, on June     , 2014 or, if such day is not a business day, on the next preceding business day (the “Exercise Period”).

  
 1.2. Exercise Procedure. 

 
 (a) This Warrant shall be deemed to have been exercised
when all of the following items have been delivered to the Company (the “Exercise Time”): 
  
 (i) a completed Exercise Agreement, as described in Section 1.3. below, executed by the Person exercising all or part of the purchase
rights represented by this Warrant (the “Purchaser”); 
  
 (ii) this Warrant; 
  
 (iii) if the Purchaser is not the Registered Holder, an Assignment or Assignments in the form set forth in Exhibit II attached hereto evidencing the assignment of this Warrant to the Purchaser; and 
  
 (iv) either (x) a check payable to the Company in an amount
equal to the product of (A) the Exercise Price (as such term is defined in Section 2 hereof) 
  

 (v) multiplied by (B) the number of Warrant Shares being purchased upon such
exercise (the “Aggregate Exercise Price”), (y) the surrender to the Company of securities of the Company having a value equal to the Aggregate Exercise Price of the Warrant Shares being purchased upon such exercise (which value in
the case of debt securities shall be the principal amount thereof and in the case of shares of Common Stock shall be the Fair Market Value thereof), or (z) the delivery of a notice to the Company that the Purchaser is exercising the Warrant by
authorizing the Company to reduce the number of Warrant Shares subject to the Warrant by the number of shares having an aggregate Fair Market Value equal to the Aggregate Exercise Price. 
  
 (b) Certificates for Warrant Shares purchased upon exercise of this Warrant shall be delivered by the
Company to the Purchaser within five days after the date of the Exercise Time together with any cash payable in lieu of a fraction of a share pursuant to Section 13 hereof. Unless this Warrant has expired or all of the purchase rights represented
hereby have been exercised, the Company shall prepare a new Warrant, substantially identical hereto, representing the rights formerly represented by this Warrant which have not expired or been exercised and shall, within such five-day period,
deliver such new Warrant to the Person designated for delivery in the Exercise Agreement. 
  
 (c) The Warrant Shares issuable upon the exercise of this Warrant shall be deemed to have been issued to the Purchaser at the Exercise
Time, and the Purchaser shall be deemed for all purposes to have become the Registered Holder of such Warrant Shares at the Exercise Time. 
  
 (d) The issuance of certificates for Warrant Shares upon exercise of this Warrant shall be made without charge to the Registered Holder or
the Purchaser for any issuance tax in respect thereof or other cost incurred by the Company in connection with such exercise and the related issuance of Warrant Shares. 
  
 (e) The Company shall not close its books against the transfer of this Warrant or of any Warrant Shares
issued or issuable upon the exercise of this Warrant in any manner which interferes with the timely exercise of this Warrant. The Company shall from time to time take all such action as may be necessary to assure that the par value per share of the
unissued Warrant Shares acquirable upon exercise of this Warrant is at all times equal to or less than the Exercise Price then in effect. In the event that the Company fails to comply with its obligations set forth in the foregoing sentence, the
Purchaser may (but shall not be obligated to) purchase Warrant Shares hereunder at par value, and the Company shall be obligated to reimburse the Purchaser for the aggregate amount of consideration paid in connection with such exercise in excess of
the Exercise Price then in effect. 
  
 (f) The
Company shall assist and cooperate with any reasonable request by the Registered Holder or any Purchaser which is required to make any governmental filings or obtain any governmental approvals prior to or in connection with any exercise of this
Warrant. 
  

 (g) Notwithstanding any other provision hereof, if an exercise of any portion of this
Warrant is to be made in connection with a public offering or a sale of the Company (pursuant to a merger, sale of stock or otherwise), such exercise may at the election of the Registered Holder be conditioned upon the consummation of such
transaction, in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction. 
  
 (h) The Company shall at all times reserve and keep available out of its authorized but unissued Common Stock solely for the purpose of
issuance upon the exercise of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant. All Warrant Shares which are so issuable shall, when issued and upon the payment of the applicable Exercise Price, be duly
and validly issued, fully paid and nonassessable and free from all taxes, liens and charges. The Company shall take all such actions as may be necessary to ensure that all such Warrant Shares may be so issued without violation by the Company of any
applicable law or governmental regulation or any requirements of any domestic securities exchange upon which shares of Common Stock or other securities constituting Warrant Shares may be listed (except for official notice of issuance which shall be
immediately delivered by the Company upon each such issuance). The Company will use its best efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on any domestic securities exchange upon which shares of Common Stock or
other securities constituting Warrant Shares are listed at the time of such exercise. 
  
 (i) If the Warrant Shares issuable by reason of exercise of this Warrant are convertible into or exchangeable for any other stock or
securities of the Company, the Company shall, at the Purchaser’s option and upon surrender of this Warrant by such Purchaser as provided above together with any notice, statement or payment required to effect such conversion or exchange of
Warrant Shares, deliver to such Purchaser (or as otherwise specified by such Purchaser) a certificate or certificates representing the stock or securities into which the Warrant Shares issuable by reason of such conversion are convertible or
exchangeable, registered in such name or names and in such denomination or denominations as such Purchaser has specified. 
  
 (j) The Company shall not, and shall not permit its subsidiaries to, directly or indirectly, by any action (including, without limitation,
reincorporation in a jurisdiction other than Delaware, if such entity is a Delaware corporation, amending its certificate of incorporation or through any Organic Change, issuance or sale of securities or any other voluntary action) avoid or seek to
avoid the observance or performance of any of the terms of this Warrant or impair or diminish its value (except for any action which ratably affects all Warrant Shares and shares of Common Stock), but shall at all times in good faith assist in the
carrying out of all such terms of this Warrant. Without limiting the generality of the foregoing, the Company shall (a) obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be
necessary to enable the Company to perform its obligations under this Warrant and (b) not undertake any reverse stock split, 

  

 
combination, reorganization or other reclassification of its capital stock which would have the effect of making this Warrant exercisable for less than one
share of Common Stock. 
  
 1.3. Exercise
Agreement. Upon any exercise of this Warrant, the Purchaser shall deliver to the Company an Exercise Agreement in substantially the form set forth in Exhibit I attached hereto, except that if the Warrant Shares are not to be issued in the
name of the Registered Holder, the Exercise Agreement shall also state the name of the Person to whom the certificates for the Warrant Shares are to be issued, and if the number of Warrant Shares to be issued does not include all of the Warrant
Shares purchasable hereunder, it shall also state the name of the Person to whom a new Warrant for the unexercised portion of the rights hereunder is to be issued. 
  
 Section 2. Adjustment of Exercise Price and Number of Shares. In order to prevent dilution of the rights granted
under this Warrant, the Initial Exercise Price shall be subject to adjustment from time to time as provided in this Section 2 (as so adjusted, the “Exercise Price”), and the number of Warrant Shares obtainable upon exercise of this
Warrant shall be subject to adjustment from time to time, each as provided in this Section 2. 
  
 2.1. Adjustment of Exercise Price and Number of Shares upon Issuance of Common Stock. If and whenever, on or after January 1, 2005,
the Company issues or sells, or in accordance with Section 2.2. is deemed to have issued or sold, other than pursuant to a Permitted Issuance or pursuant to the Purchase Rights covered by Section 3, any shares of Common Stock for a consideration per
share less than the Fair Market Value per share of the Common Stock determined as of the date of such issuance or sale, then immediately upon such issuance or sale the Exercise Price shall be reduced to equal the amount determined by multiplying the
Exercise Price in effect immediately prior to such issuance or sale by a fraction, the numerator of which will be the sum of (1) the number of shares of Common Stock Deemed Outstanding immediately prior to such issuance or sale multiplied by the
Fair Market Value per share of the Common Stock determined as of the date of such issuance or sale, plus (2) the consideration, if any, received by the Company upon such issuance or sale, and the denominator of which will be the product derived by
multiplying such Fair Market Value per share of the Common Stock by the number of shares of Common Stock Deemed Outstanding immediately after such issuance or sale. Upon each such adjustment of the Exercise Price hereunder, the number of Warrant
Shares acquirable upon exercise of this Warrant shall be adjusted to equal the number of shares determined by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of Warrant Shares acquirable upon exercise of
this Warrant immediately prior to such adjustment and dividing the product thereof by the Exercise Price resulting from such adjustment. 
  
 2.2. Effect on Exercise Price of Certain Events. For purposes of determining the adjusted Exercise Price under Section 2.1., the
following shall be applicable: 
  
 (a)
Issuance of Rights or Options. If the Company in any manner grants any rights or options to subscribe for or to purchase Common Stock or any stock or other securities convertible into or exchangeable for Common Stock (including without
limitation 

  

 
convertible common stock) (such rights or options being herein called “Options” and such convertible or exchangeable stock or securities
being herein called “Convertible Securities”) and the price per share for which Common Stock is issuable upon the exercise of such Options or upon conversion or exchange of such Convertible Securities is less than the Fair Market
Value per share of the Common Stock then in effect, then the total maximum number of shares of Common Stock issuable upon the exercise of such Options or upon conversion or exchange of the total maximum amount of such Convertible Securities issuable
upon the exercise of such Options shall be deemed to be outstanding and to have been issued and sold by the Company for such price per share. For purposes of this paragraph, the “price per share for which Common Stock is issuable upon exercise
of such Options or upon conversion or exchange of such Convertible Securities” is determined by dividing (A) the total amount, if any, received or receivable by the Company as consideration for the granting of such Options, plus the minimum
aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, plus in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any,
payable to the Company upon the issuance or sale of such Convertible Securities and the conversion or exchange thereof, by (B) the total maximum number of shares of Common Stock issuable upon exercise of such Options or upon the conversion or
exchange of all such Convertible Securities issuable upon the exercise of such Options. No further adjustment of the Exercise Price shall be made upon the actual issuance of such Common Stock or of such Convertible Securities upon the exercise of
such Options or upon the actual issuance of such Common Stock upon conversion or exchange of such Convertible Securities. 
  
 (b) Issuance of Convertible Securities. If the Company in any manner issues or sells any Convertible Securities (other than the
Purchase Rights covered by Section 3 hereof or a Permitted Issuance) and the price per share for which Common Stock is issuable upon such conversion or exchange is less than the Fair Market Value per share of the Common Stock then in effect, then
the maximum number of shares of Common Stock issuable upon conversion or exchange of such Convertible Securities shall be deemed to be outstanding and to have been issued and sold by the Company for such price per share. For the purposes of this
paragraph, the “price per share for which Common Stock is issuable upon such conversion or exchange” is determined by dividing (A) the total amount received or receivable by the Company as consideration for the issue or sale of such
Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange thereof, by (B) the total maximum number of shares of Common Stock issuable upon the conversion or
exchange of all such Convertible Securities. No further adjustment of the Exercise Price shall be made upon the actual issue of such Common Stock upon conversion or exchange of such Convertible Securities, and if any such issue or sale of such
Convertible Securities is made upon exercise of any Options for which adjustments of the Exercise Price have been or are to be made pursuant to other provisions of this Section 2.2., no further adjustment of the Exercise Price shall be made by
reason of such issue or sale. 
  
 (c) Change
in Option Price or Conversion Rate. If either the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, 

  

 
conversion or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exchangeable for Common Stock
shall change at any time, the Exercise Price in effect at the time of such change shall be adjusted to the Exercise Price which would have been in effect at such time had such Options or Convertible Securities still outstanding provided for such
changed purchase price, additional consideration or changed conversion rate, as the case may be, at the time initially granted, issued or sold and the number of Warrant Shares shall be correspondingly readjusted. 
  
 (d) Treatment of Expired Options and Unexercised
Convertible Securities. Upon the expiration of any Option or the termination of any right to convert or exchange any Convertible Securities, in either case without the exercise of such Option or right, the Exercise Price then in effect and the
number of Warrant Shares acquirable hereunder shall be adjusted to the Exercise Price and the number of shares which would have been in effect at the time of such expiration or termination had such Option or Convertible Securities, to the extent
outstanding immediately prior to such expiration or termination, never been issued. 
  
 (e) Calculation of Consideration Received. If any Common Stock, Options or Convertible Securities are issued or sold or deemed to
have been issued or sold for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor. In case any Common Stock, Options or Convertible Securities are issued or sold for a consideration other
than cash, the amount of the consideration other than cash received by the Company shall be the fair value of such consideration, except where such consideration consists of marketable securities, in which case the amount of consideration received
by the Company shall be the market price thereof as of the date of receipt. In case any Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger or other business combination
in which the Company is the surviving entity, the amount of consideration therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or
Convertible Securities, as the case may be. The fair value of any consideration other than cash or marketable securities shall be determined jointly by the Company and the Required Holders. If such parties are unable to reach agreement within a
reasonable period of time, such fair value shall be determined by an appraiser jointly selected by the Company and the Required Holders, whose determination shall be final and binding on the Company and all Registered Holders of Warrants. The fees
and expenses of such appraiser shall be paid by the Company. 
  
 (f) Integrated Transactions. In case any Option is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction in which no specific
consideration is allocated to such Options by the parties thereto, the Option shall be deemed to have been issued for no consideration. 
  
 (g) Treasury Shares. The number of shares of Common Stock outstanding at any given time does not include shares owned or held by or
for the account of the 

  

 
Company or any subsidiary of the Company and the disposition of any shares so owned or held shall be considered an issue or sale of Common Stock. 

 
 (h) Record Date. If the Company takes a record of
the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution payable in Common Stock, Options or Convertible Securities or (B) to subscribe for or purchase Common Stock, Options or Convertible
Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the
granting of such right of subscription or purchase, as the case may be. 
  
 2.3. Subdivision or Combination of Common Stock. If the Company at any time on or after January 1, 2005, subdivides (by any stock split, stock dividend, recapitalization or otherwise) the Common Stock into a
greater number of shares or pays a dividend or makes a distribution to holders of the Common Stock in the form of shares of Common Stock, the Exercise Price in effect immediately prior to such subdivision shall be proportionately reduced and the
number of Warrant Shares obtainable upon exercise of this Warrant shall be proportionately increased. If the Company at any time combines (by reverse stock split or otherwise) the Common Stock into a smaller number of shares, the Exercise Price in
effect immediately prior to such combination shall be proportionately increased and the number of Warrant Shares obtainable upon exercise of this Warrant shall be proportionately decreased. 
  
 2.4. Organic Change. Any recapitalization,
reorganization, reclassification, consolidation, merger, sale of all or substantially all of the Company’s assets or other transaction which is effected in such a way that holders of Common Stock are entitled to receive (either directly or upon
subsequent liquidation) stock, securities or assets with respect to or in exchange for Common Stock is referred to herein as an “Organic Change”. Prior to the consummation of any Organic Change, the Company shall make appropriate
provision to ensure that each Registered Holder of Warrants shall thereafter have the right to acquire and receive upon exercise thereof, in lieu of or addition to (as the case may be) the Warrant Shares immediately theretofore acquirable and
receivable upon exercise of such Registered Holder’s Warrants, such shares of stock, securities or assets as may be issued or payable with respect to or in exchange for the number of Warrant Shares immediately theretofore acquirable and
receivable upon exercise of such Registered Holder’s Warrants had such Organic Change not taken place. In any such case, the Company shall make appropriate provision with respect to such Registered Holder’s rights and interests to insure
that the provisions hereof (including this Section 2) shall thereafter be applicable to the Warrants (including, in the case of any such Organic Change in which the successor entity or purchasing entity is other than the Company, an immediate
adjustment of the Exercise Price to the value for the Common Stock reflected by the terms of such Organic Change and a corresponding immediate adjustment in the number of Warrant Shares acquirable and receivable upon exercise of the Warrants, if the
value so reflected is less than the Fair Market Value of the Common Stock in effect immediately prior to such Organic Change). The Company shall not effect any such Organic Change unless, prior to the consummation thereof, the successor entity (if
other than the Company) resulting from such 

  

 
Organic Change (including a purchaser of all or substantially all the Company’s assets) assumes by written instrument the obligation to deliver to each
Registered Holder of Warrants such shares of stock, securities or assets as, in accordance with the foregoing provisions, such Registered Holder may be entitled to acquire upon exercise of Warrants. 
  
 2.5. Certain Events. If any event occurs of the type
contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features but excluding any
Permitted Issuance), then the Company’s board of directors shall exercise their reasonable judgment consistent with the fundamental intent of such provisions in making an appropriate adjustment in the Exercise Price and the number of Warrant
Shares obtainable upon exercise of this Warrant so as to protect the rights of the Registered Holder of this Warrant. 
  
 2.6. Notices. 
  
 (a) Immediately upon any adjustment of the Exercise Price, the Company shall give written notice thereof to the Registered Holder, setting
forth in reasonable detail and certifying the calculation of such adjustment. 
  
 (b) The Company shall give written notice to the Registered Holder at least 30 days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the
Common Stock, (B) with respect to any pro rata subscription offer to holders of Common Stock, or (C) for determining rights to vote with respect to any Organic Change, dissolution or liquidation. 
  
 (c) The Company shall also give written notice to the
Registered Holder at least 30 days prior to the date on which any Organic Change, dissolution or liquidation shall take place. 
  
 Section 3. Purchase Rights. If at any time on or after January 1, 2005, the Company grants, issues or sells any options, convertible securities or
rights to purchase stock, warrants, securities or other property pro rata to the record holders of the Common Stock (the “Purchase Rights”), then the Company shall grant, issue or sell (as the case may be) to the Registered Holder
the aggregate Purchase Rights which such Registered Holder would have acquired if such Registered Holder had held the maximum number of Warrant Shares acquirable upon complete exercise of this Warrant immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. 
  
 Section 4. Definitions. The following terms have the meanings set
forth below: 
  
 “Common Stock” means the
Company’s Common Stock, $0.00001 par value per share, or any securities into which such Common Stock is hereafter converted or exchanged. 
  

 “Common Stock Deemed Outstanding” means, at any given time, the number of shares of all
classes of the Company’s common stock actually outstanding at such time, plus the number of shares of the Company’s common stock deemed to be outstanding pursuant to Section 2.2.(a) or 2.2.(b) hereof. 
  
 “Fair Market Value” means (i) the average of the closing
sales prices of the Common Stock on all domestic securities exchanges on which the Common Stock is listed, or (ii) if there have been no sales on any such exchange on any day, the average of the highest bid and lowest asked prices on all such
exchanges at the end of such day or, (iii) if on any day the Common Stock is not so listed, the sales price for the Common Stock as of 4:00 P.M., New York time, as reported on the NASDAQ National Market or, (iv) if the Common Stock is not reported
on the NASDAQ National Market, the average of the representative bid and asked quotations for the Common Stock as of 4:00 P.M., New York time, as reported on the NASDAQ interdealer quotation system, or any similar successor organization, in each
such case averaged over a period of 21 trading days consisting of the day as of which “Fair Market Value” is being determined and the 20 consecutive trading days prior to such day. Notwithstanding the foregoing, if at any time of
determination either (x) the Common Stock is not registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and either listed on a national securities exchange or authorized for quotation in the NASDAQ system, or (y) less
than 25% of the outstanding Common Stock is held by the public free of transfer restrictions under the Securities Act of 1933, as amended, then Fair Market Value shall be determined jointly by the Company and the Required Holders. If such parties
are unable to reach agreement within a reasonable period of time, such Fair Market Value shall be determined by an appraiser jointly selected by the Company and the Required Holders, whose determination shall be final and binding on the Company and
all Registered Holders of Warrants. The fees and expenses of such appraiser shall be paid by the Company. 
  
 “Permitted Issuance” means any issuance by the Company of (a) Common Stock, Options, or Convertible Securities on or prior to the date
hereof; (b) Common Stock upon exercise of this Warrant; (c) Common Stock upon the conversion or exchange of any shares of any class of Common Stock into another class of Common Stock; or (d) Common Stock pursuant to an underwritten offering of
Common Stock registered under the Securities Act of 1933, as amended. 
  
 “Person” means any individual, partnership, joint venture, corporation, trust, unincorporated organization or government or department or agency thereof. 
  
 “Registered Holder” means the holder of this Warrant as reflected in the records of the Company maintained
pursuant to Section 12. 
  
 “Required Holders”
means Bruckmann, Rosser, Sherrill & Co. II, L.P. and its successors and assigns. 
  
 “Warrant Shares” means shares of Common Stock issuable upon exercise of the Warrants; provided, that if the securities issuable upon exercise of the Warrants are issued by an 

  

 
entity other than the Company or there is a change in the class of securities so issuable, then the term “Warrant Shares” shall mean shares of the
security issuable upon exercise of the Warrants if such security is issuable in shares, or shall mean the equivalent units in which such security is issuable if such security is not issuable in shares. 
  
 “Warrants” means those certain Stock Purchase Warrants
issued by the Company pursuant to that certain Warrant Agreement, dated as of June 10, 2004, by and among the Company and the Purchasers party thereto (the “Warrant Agreement”), which together with the shares of Common Stock
issuable upon exercise of the New Options (as defined in the Warrant Agreement), represent the right to purchase from the Company 66.7% of the Common Stock Deemed Outstanding at the close of business on December 31, 2004 (as calculated and adjusted
pursuant to the terms thereof) together with any stock purchase warrants issued in substitution, exchange or replacement therefor. 
  
 Section 5. Voting Rights; Limitations of Liability. This Warrant shall entitle the Registered Holder hereof to all voting rights or other rights as
a stockholder of the Company on an as-if converted basis. No provision hereof, in the absence of affirmative action by the Registered Holder to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Registered Holder
shall give rise to any liability of such Registered Holder for the Exercise Price of Warrant Shares acquirable by exercise hereof or as a stockholder of the Company. 
  
 Section 6. Restrictions. This Warrant and all rights hereunder are transferable, in whole or in part, without charge
to the Registered Holder (subject to the provisions of paragraph 1.2.(d) hereof), upon surrender of this Warrant with a properly executed Assignment (in the form of Exhibit II attached hereto) at the principal office of the Company. The
Registered Holder agrees that it will not sell, transfer or otherwise dispose of this Warrant or any Warrant Shares of restricted Common Stock, in whole or in part, except pursuant to an effective registration statement under the Securities Act of
1933, as amended, or an exemption from registration thereunder. 
  
 Section 7. Warrant Exchangeable for Different Denominations. This Warrant is exchangeable, upon the surrender hereof by the Registered Holder at the principal office of the Company, for new Warrants of like tenor representing in the
aggregate the purchase rights hereunder, and each of such new Warrants shall represent such portion of such rights as is designated by the Registered Holder at the time of such surrender. At the request of the Registered Holder (pursuant to a
transfer of Warrants or otherwise), this Warrant may be exchanged for one or more Warrants to purchase Common Stock. The date the Company initially issues this Warrant shall be deemed to be the date of issuance hereof regardless of the number of
times new certificates representing the unexpired and unexercised rights formerly represented by this Warrant shall be issued. 
  
 Section 8. Exchange. In the event that it becomes unlawful or, in the reasonable judgment of any Registered Holder of this Warrant, unduly
burdensome by reason of a change in legal or regulatory considerations or the interpretation thereof affecting the ability of financial 

  

 
institutions or their affiliates to hold equity securities, or any material change (including a reduction in the number of shares of Common Stock
outstanding) in the capital structure of the Company, to hold any or all of the Warrants or Warrant Shares, the Registered Holder of this Warrant shall have the right to require the Company to use its best efforts to permit all or part of such
Registered Holder’s Warrants or Warrant Shares to be exchanged for nonvoting stock or similar interests that convey equivalent economic benefits to such Warrants or Warrant Shares and include equivalent anti-dilution protection. To the extent
that the Company may lawfully do so after the exercise of its best efforts, any such exchange shall occur as soon as practicable but in any event within 60 days after written notice by the Registered Holder of this Warrant to the Company (or such
earlier date if required to comply with applicable law). 
  
 Section 9. Replacement. Upon receipt of evidence reasonably satisfactory to the Company (an affidavit of the Registered Holder shall be satisfactory) of the ownership and the loss, theft, destruction or mutilation of any certificate
evidencing this Warrant, and in the case of any such loss, theft or destruction, upon receipt of indemnity reasonably satisfactory to the Company (provided that if the Registered Holder is a financial institution or other institutional investor its
own agreement shall be satisfactory), or, in the case of any such mutilation upon surrender of such certificate, the Company shall (at its expense) execute and deliver in lieu of such certificate a new certificate of like kind representing the same
rights represented by such lost, stolen, destroyed or mutilated certificate and dated the date of such lost, stolen, destroyed or mutilated certificate. 
  
 Section 10. Notices. Except as otherwise expressly provided herein, all notices and deliveries referred to in this Warrant shall be in writing,
shall be delivered personally, sent by registered or certified mail, return receipt requested and postage prepaid or sent via nationally recognized overnight courier or via facsimile, and shall be deemed to have been given when so delivered (or when
received, if delivered by any other method) if sent (i) to the Company, at its principal executive offices and (ii) to a Registered Holder, at such Registered Holder’s address as it appears in the records of the Company (unless otherwise
indicated by any such Registered Holder). 
  
 Section 11.
Amendment. This Warrant may be amended only by a written instrument signed by the Company and the Registered Holder. 
  
 Section 12. Warrant Register. The Company shall maintain at its principal executive offices books for the registration and the registration of
transfer of Warrants. The Company may deem and treat the Registered Holder as the absolute owner hereof (notwithstanding any notation of ownership or other writing hereon made by anyone) for all purposes and shall not be affected by any notice to
the contrary. 
  
 Section 13. Fractions of Shares. The
Company may, but shall not be required to, issue a fraction of a Warrant Share upon the exercise of this Warrant in whole or in part. As to any fraction of a share which the Company elects not to issue, the Company shall make a cash payment in
respect of such fraction in an amount equal to the same fraction of the Fair Market Value of a Warrant Share on the date of such exercise. 
  

 Section 14. Descriptive Headings; Interpretation. The descriptive headings of this Warrant are
inserted for convenience only and do not constitute a substantive part of this Warrant. The use of the word “including” in this Warrant shall be by way of example rather than by limitation. 
  
 Section 15. Governing Law. This Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the
application of the laws of any jurisdiction other than those of the State of Delaware. 
  
 * * * * * * 
  
 [signature page follows] 
  

 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed and attested by its duly authorized
officers under its corporate seal and to be dated as of the date hereof. 
  

			
	HEALTHESSENTIALS SOLUTIONS, INC.
		
	By:	 	 
	 	 	 Name: Michael R. Barr

	 	 	 Title: Chief Executive Officer

  

	
	Attest:
	
	  
	 Name: Norman J. Pfaadt

	 Title: Chief Financial OfficerWarrant for Issuance of Common Stock

 Exhibit 10.29 
  
 WARRANT FOR ISSUANCE OF COMMON STOCK 
 OF 
 HEALTHESSENTIALS SOLUTIONS, INC. 
  
 THE TRANSFER OF THIS WARRANT IS RESTRICTED BY THE TERMS OF THIS WARRANT. EXCEPT AS PROVIDED HEREIN, THIS WARRANT MAY NOT BE
GIVEN, SOLD, PLEDGED OR OTHERWISE TRANSFERRED. 
  

			
	 No. W-1
	  	Warrant to Purchase 95,098 Shares of Common Stock
		
	 	  	Void after May 1, 2012

  
 For value received,
HEALTHESSENTIALS SOLUTIONS, INC., a Delaware corporation (the “Company”) hereby certifies that, Arthur Barlaan and Jocelyn Barlaan, each an individual with a primary residence in Florida, or permitted assigns (the “Holder”), is
entitled, subject to the terms set forth below, to purchase from the Company, Ninety-five Thousand Ninety-eight (95,098) shares of common stock, without par value, of the Company (“Warrant Shares”), as constituted on April 30, 2002 (the
“Warrant Issue Date”), upon surrender hereof, at the principal office of the Company referred to below, with the Notice of Exercise attached hereto duly executed, and simultaneous payment therefor in lawful money of the United States as
hereinafter provided, at the per Warrant Share price of Zero Dollars and One Cent ($0.01) (the “Exercise Price”). The number, character and Exercise Price of such shares of Warrant Shares are subject to adjustment as provided below. The
term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is registered and its transfer may be registered upon the books maintained for that
purpose by the Company by delivery of this Warrant duly endorsed. 
  
 1. Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during the term commencing on the Warrant Issue Date and ending at 5:00 p.m., Eastern Standard
Time, on May 1, 2012, and shall be void thereafter. 
  
 2.
Exercise of Warrant. 
  
 2.1.
Method. The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any time, or from time to time, during the term hereof as described in Section 1 above, by the surrender of this Warrant and the
Notice of Exercise annexed hereto duly completed and executed by the Holder, at the office of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder), upon payment (a) in cash or by wire
transfer to a bank account designated by the Company or by a certified or cashier’s check, (b) by cancellation by the Holder of indebtedness of the Company to the Holder, or (c) by a combination of (a) and (b), of the Exercise Price of the
shares to be purchased; provided, however, that if less than all of the purchase rights represented by this Warrant are exercised, such exercise shall involve the purchase of at least Ten Thousand (10,000) shares of Warrant Shares, adjusted as
provided in Section 6 below. 
  
 2.2.
Effect. This Warrant shall be deemed to have been exercised at the time of its surrender for exercise as provided above, and the person entitled to receive the shares of 

  

 
common stock issuable upon such exercise (“Common Stock”) shall be treated for all purposes as the holder of record of such shares at and after
such time. As promptly as practicable on or after such date and in any event within ten (10) days thereafter, the Company at its expense shall issue to the person entitled to receive the same a certificate for the number of shares of Common Stock
issuable upon such exercise. If this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant exercisable for the number of shares for which this Warrant may then be exercised. 
  
 2.3. Holder Not A Shareholder. The Holder shall
neither be entitled to vote nor receive dividends nor be deemed the holder of Common Stock or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose until the Warrant has been exercised as
provided in this Section 2. 
  
 2.4. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall
make a cash payment equal to the Exercise Price multiplied by such fraction. 
  
 3. Ownership Restrictions. 
  
 3.1. Record Ownership. The Company shall maintain a register of the Holders of the Warrants (the “Register”) showing their names and addresses and the serial numbers and number of Common Shares
purchasable issued to or transferred of record by them from time to time. The Register may be maintained in electronic, magnetic or other computerized form. The Company may treat the person named as the Holder of this Warrant in the Register as the
sole owner of this Warrant. The Holder of this Warrant is the person exclusively entitled to receive notifications with respect to this Warrant, exercise it to purchase shares of Common Stock and otherwise exercise all of the rights and powers as
the absolute owner hereof. 
  
 3.2.
Registration of Transfer. This Warrant may not be transferred by the Holder, except upon approval by the Company; provided, however, that any requested transfers by the Holder to a trust where the beneficiary of such trust is the Holder will
not be unreasonably withheld. Permitted transfers of this Warrant may be registered on the books of the Company maintained for such purpose pursuant to Section 3.1 above (i.e., the Register). Transfers shall be registered when this Warrant is
presented to the Company duly endorsed with a request to register the transfer hereof and the Company has accepted such transfer. When this Warrant is presented for transfer and duly transferred hereunder, it shall be canceled and a new Warrant
showing the name of the transferee as the Holder thereof shall be issued in lieu hereof. 
  
 3.3. Worn and Lost Warrants. If this Warrant becomes worn, defaced or mutilated but is still substantially intact and recognizable,
the Company or its agent may issue a new Warrant in lieu hereof upon its surrender. If this Warrant is lost, destroyed or wrongfully taken, the Company shall issue a new Warrant in place of the original Warrant if the Holder so requests by written
notice to the Company and the Holder has delivered to the Company an indemnity agreement reasonably satisfactory to the Company with an affidavit of the Holder that this Warrant has been lost, destroyed or wrongfully taken. 
  

 - 2 - 

 3.4. Restrictions on Transfer. This Warrant and the Common Stock issuable upon the
exercise hereof have not been registered under the Act or any applicable state securities laws and this Warrant and the Common Stock issuable upon the exercise of this Warrant may not be offered for sale or sold unless such offer or sale is
registered under the appropriate securities laws or such transfer is exempt from such registration and the Company has received an opinion of counsel, reasonably satisfactory to the Company in form and substance, stating that such offer or sale is
exempt from registration under applicable state and federal securities laws. In addition, the Holder may only transfer this Warrant and the Common Stock issuable upon the exercise hereof with the prior written consent of the Company. Further, the
Common Stock issuable upon exercise hereof shall be subject to the Company’s standard shareholders agreement. 
  
 3.5. Legend. Upon any exercise of a Warrant, the certificates representing the securities purchased thereby shall bear the
following legend: 
  
 THESE SECURITIES HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS AND THESE SECURITIES MAY NOT BE OFFERED FOR SALE OR SOLD UNLESS THEY ARE REGISTERED UNDER THE APPROPRIATE SECURITIES LAWS OR THEY OR SUCH OFFER OR SALE ARE EXEMPT FROM SUCH
REGISTRATION AND THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL TO THAT EFFECT, REASONABLY SATISFACTORY TO THE COMPANY IN FORM AND SUBSTANCE. 
  
 3.6. Warrant Agent. The Company may, by written notice to the Holder appoint an agent for the purpose of maintaining the Register
issuing Common Stock or other securities then issuable upon the exercise of this Warrant, exchanging or transferring this warrant, or any or all of the foregoing. Thereafter, any such registration issuance, exchange, or transfer, as the case may be,
shall be made at the office of such agent. 
  
 4. Reservation
of Stock. The Company covenants that, during the term this Warrant is exercisable, the Company will reserve from its authorized and unissued Common Stock a sufficient number of Shares to provide for the issuance of Common Stock upon the exercise
of this Warrant and, if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of the Common Stock, the Corporation will take such corporate action as
may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purpose, including without limitation, engaging in best efforts to obtain the
requisite shareholder approval of any necessary amendment to its Certificate of Incorporation (the “Articles”). The Company further covenants that all shares that may be issued upon the exercise of rights represented by this Warrant, upon
exercise of the rights represented by this Warrant and payment of the Exercise Price, all as set forth herein, will be duly authorized, validly issued, fully paid, non-assessable and free from all taxes, liens and charges in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously or otherwise specified herein). The Company agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of
executing stock certificates to execute and issue the necessary certificates for shares of Common Stock upon the exercise of this Warrant. 
  

 - 3 - 

 5. Distributions. If: (a) the Company sets a record date for the holders of its Common Stock (or
other stock or securities at the time receivable upon the exercise of this Warrant) for the purpose of entitling them to receive any dividend or other distribution, or any right to subscribe for or purchase any shares of stock of any class or any
other securities, or to receive any other right, or; (b) there is any capital reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company with or into another entity, or any
conveyance of all or substantially all of the assets of the Company or (c) there is any voluntary dissolution, liquidation or winding-up of the Company, the Company will mail to the Holder a notice specifying, as the case may be, (A) the record date
for the purpose of such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (B) the date on which such reorganization, reclassification, consolidation, merger, conveyance, dissolution,
liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such other Stock or securities) for securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation or winding-up. Such notice shall be mailed at least fourteen (14) days prior to the date therein specified. 
  
 6. Adjustments. The Exercise Price and the number of shares purchasable hereunder are subject to adjustment from time
to time as follows: 
  
 6.1. Merger, Sale of
Assets, etc. If, at any time while this Warrant or any portion thereof is outstanding and unexpired, there shall be (a) a reorganization (other than a combination, reclassification, exchange or subdivision of shares otherwise provided for
herein), (b) a merger or consolidation of the Company with or into another corporation in which the Company is not the surviving entity, or a reverse triangular merger in which the Company is the surviving entity but the shares of the Company’s
capital stock outstanding immediately prior to the merger are converted by virtue of the merger into other property, whether in the form of securities, cash, or otherwise, or (c) a sale or transfer of the Company’s properties and assets as, or
substantially as, an entirety to any other person, then, as a part of such reorganization, merger, consolidation, sale or transfer, lawful provision shall be made so that the holder of this Warrant shall thereafter be entitled to receive upon
exercise of this Warrant, during the period specified herein, and upon payment of the Exercise Price then in effect, the number of shares of stock or other securities or property of the successor corporation resulting from such reorganization,
merger, consolidation, sale or transfer that a holder of the shares deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization, consolidation, merger, sale or transfer if this Warrant had been exercised
immediately before such reorganization, merger, consolidation, sale or transfer, all subject to further adjustment as provided in this Section 6. The foregoing provisions of this Section 6.1 shall similarly apply to successive reorganizations,
consolidations, mergers, sales and transfers and to the stock or securities of any other corporation that are at the time receivable upon the exercise of this Warrant. If the per-share consideration payable to the Holder hereof for shares in
connection with any such transaction is in a form other than cash or marketable securities, then the value of such consideration shall be determined in good faith by the Company’s Board of Directors. In all events, appropriate adjustment (as
determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder after the transaction, to the end that the provisions of
this Warrant shall be applicable after that event, as 

  

 - 4 - 

 
near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this Warrant. 
  
 6.2. Reclassification, etc. If the Company, at any
time while this Warrant or any portion thereof remains outstanding and unexpired, by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different
number of securities of any other class or classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that were
subject to the purchase rights under this Warrant immediately prior to such reclassification or other change and the Base Price and Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this
Section 6. 
  
 6.3. Split, Subdivision or
Combination. If the Company, at any time while this Warrant or any portion thereof remains outstanding and unexpired, shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number
of securities of the same class, the Base Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination, and the number of shares of Common Stock for
which this Warrant is exercisable shall be proportionately increased in the case of a split or subdivision or proportionately decreased in the case of a combination. 
  
 6.4. Adjustment for Dividends in Stock or Other Securities or Property. If, while this Warrant or any
portion hereof remains outstanding and unexpired, the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record date fixed for the determination of eligible
shareholders, shall have become entitled to receive, without payment therefor, other or additional stock or other securities or property (other than cash) of the Company by way of dividend, then, and in each case, this Warrant shall represent the
right to acquire, in addition to the number of shares of the security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of such other or additional stock or other security or property
(other than cash) of the Company that such holder would hold on the date of such exercise had it been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period from the
date hereof to and including the date of such exercise, retained such shares and/or all other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this
Section 6. 
  
 6.5. Certificate as to
Adjustments. Upon the occurrence of each adjustment pursuant to this Section 6, the Company at its expense shall promptly compute such adjustment in accordance with the terms hereof and furnish to the Holder a certificate setting forth such
adjustment and showing in detail the facts upon which such adjustment is based, and the Exercise Price before and after the adjustment. The Company shall, at any time upon the written request of any Holder, furnish to such Holder a certificate
setting forth: (a) such adjustments; and (b) the Exercise Price then in effect; and (c) the number of shares and the amount, if any, of other property that at the time would be received upon the exercise of the warrant. 
  

 - 5 - 

 6.6. No Impairment. The Company will not, by any voluntary action, avoid or seek
to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Section 6 and in the taking of all such
actions as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment. 
  
 7. Registration Rights. The Holder shall be able to participate in any Initial Public Offering of the Company upon the same terms and conditions as
management of the Company. If the Company proposes to register any its securities under the Securities Act of 1933, as amended, for sale to the public, whether for its own account or for the account of other security holders or both, the Company at
each such time will give written notice to the Holder of its intention to do so. Upon the written request of the Holder, given within 20 days after the date of any such notice, to register any of its securities held hereunder (which request shall
state the intended method of disposition thereof), the Company will use its best efforts to cause the securities as to which registration shall have been so requested to be included in the securities to be covered by such registration statement
proposed to be filed by the Company, subject to any limitations or restrictions placed on the securities owned by the management of the Company under the terms of the Initial Public Offering. If requested, the Company shall provide for the benefit
of the Holder and others claiming through the Holder, an agreement or agreements containing representations, warranties, indemnities, and other agreements then customarily included by an issuer in underwriting agreements with respect to initial and
secondary underwritten distributions, and in connection therewith, if an underwriting agreement is entered into, cause the same to contain customary indemnification provisions and procedures and such other provisions and procedures reasonably
acceptable to, and for the benefit of, the underwriters. For purposes of this Section 7, “Initial Public Offering” shall mean the sale by either the Company or any of its subsidiaries of its capital stock pursuant to a registration
statement on Form S-1 or otherwise under the Securities Act. 
  
 8. Amendments. This Warrant may not be amended without the prior written consent of the Holder. 
  
 9. Notices. Any notice, certificate or other communication which is required or convenient under the terms of this Warrant shall be duly given if
it is in writing and delivered in person or mailed by first class mail, postage prepaid, and directed to the Holder of the Warrant at its address as it appears on the Register, or, if to the Company, to its principal executive offices. The time when
such notice is sent shall be the time of the giving of the notice. 
  
 10. Time. Where this Warrant provides for a payment or performance on a Saturday or Sunday or a public holiday in the Commonwealth of Kentucky, such performance may be made on the next succeeding business day. 
  
 11. Rules of Construction. In this Warrant, unless the context
otherwise requires, words in the singular number include the plural, and in the plural include the singular, and words of the masculine gender include the feminine and the neuter, and when the sense so indicates, words of the neuter gender may refer
to any gender. The numbers and titles of sections contained in this Warrant are inserted for convenience of reference only, and they neither form a part of this Warrant nor are they to be used in the construction or interpretation hereof.

  

 - 6 - 

 12. Governing Law. The validity, terms, performance and enforcement of this Warrant shall be
governed by those laws of the State of Delaware that are applicable to agreements that are negotiated, executed, delivered and performed solely in the State of Delaware. 
  
 IN WITNESS WHEREOF, HEALTHESSENTIALS SOLUTIONS, INC. has caused this Warrant to be executed by its officer thereto duly
authorized. 
  

			
	 HEALTHESSENTIALS SOLUTIONS, INC.

		
	 By:
	 	 /s/ Michael R. Barr

		
	 Title:
	 	 CEO

  

 - 7 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]